Overview
Dr. Hartwig is a thoracic surgeon with a clinical focus in lung transplantation and robotic assisted minimally invasive thoracic surgery for the treatment of diseases of the chest. He serves as the Surgical Director of the Duke Lung Transplant Program and the Esophageal Center at Duke. Additionally, he directs the Surgical Office of Clinical Research, which manages the clinical research portfolio for the Department of Surgery. He also leads a successful program of clinical, basic and translational research in thoracic surgery and lung transplantation. He currently directs the Duke Ex Vivo Organ Laboratory (DEVOL), is the Chief of Lung Transplant Research, and is a faculty member at the Duke Clinical Research Institute (DCRI).
Dr. Hartwig has over 150 peer reviewed publications, received numerous awards, chaired many sessions at national and international meetings, serves regularly on NIH study sections, and is on the editorial board of many prominent journals. He has also personally mentored over pre-and post-doctoral trainees, many of whom are now engaged in their own successful research careers.
Current Appointments & Affiliations
Recent Publications
Lung transplantation from donation after circulatory death donors over 55 years old: A national analysis of outcomes and utilization.
Journal Article JHLT Open · February 2026 BACKGROUND: Lungs from older donation after circulatory death (DCD) donors are underutilized; however, these organs may represent an opportunity to expand the donor pool. Herein, we evaluated utilization and outcomes of lung transplants using lungs from ol ... Full text Open Access Link to item CiteModernization of the U.S. transplant system: Protecting donors and saving lives 1 donation at a time.
Journal Article J Heart Lung Transplant · January 2026 Full text Link to item CiteCombined heart-lung organ allocation: A glitch in the system.
Journal Article J Heart Lung Transplant · December 2025 Organ allocation guidelines prioritize patients at risk of waitlist mortality. In the United States, both the heart and lung allocation systems were revised within the last ten years. There is no specific allocation system for patients listed for combined ... Full text Link to item CiteRecent Grants
US National OCS Lung Thoracic Organ Perfusion (TOP) Registry
Clinical TrialPrincipal Investigator · Awarded by TransMedics · 2024 - 2034The Post-Lung Transplant Impact of Alveolar Macrophage Senescence in Aged Donor Lungs
ResearchAdvisor · Awarded by National Institutes of Health · 2025 - 20302/3 CTSA K12 Program at Duke University
ResearchMentor · Awarded by National Institutes of Health · 2025 - 2030View All Grants